Authors

1 Associate professor of orthopedic surgery

2 Orthopedic surgery fellowship Shahid Beheshti university of medical sciences Tehran Iran

Abstract

 
Background: Spinal fusion is a surgical method to treat degenerative diseases of the spine. We studied the effect of bone graft soaked with zolendronic acid (ZA) on spinal fusion.
Method: 60 patients with degenerative disease, scheduled for spinal fusion were randomly divided into 2 equal groups, receiving either local bone graft or local bone graft plus topical zoledronic acid. The cases were studied with visual analogue scale (VAS), Oswestry low back disability questionnaire, and radiographic bone bridge formation with a 12-months follow-up.
Results: 57 patients completed the study: 27 patients in “control group” and 30 patients in “case group”. VAS Score was significantly lower in case group in comparison with control one after 12 months (P value:0.00).In the point of Oswestry low back disability questionnaire score(ODI)score the mean score was decreased significantly in “case group” in comparison with “control group”(P value =0.006). Radiographic grades A or B bone  bridging was more frequently observed in Zoledronic acid group at 12 months post-operation compared with the control group (p value=0.00).
Conclusion: This study demonstrates that addition of Zolendronic Acid to bone grafting in the spinal fusion of elderly people increases the fusion rate and is associated with better clinical and functional outcome.

Keywords

  1. Ponnusamy KE, Iyer S, Gupta G, Khanna AJ. Instrumentation of the osteoporotic spine: Biomechanical and clinical considerations. Spine J. 2011;11(1):54-63.
  2. Ding Q, Chen J, Fan J, Li Q, Yin G, Yu L. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients. Eur Spine J. 2017;26(11):2969-77.
  3. Carlisle E, Fischgrund JS. Bone morphogenetic proteins for spinal fusion. Spine J. 2005;5(6 Suppl):240S-9S.
  4. Deyo RA, Ching A, Matsen L, Martin BI, Kreuter W, Jarvik JG, et al. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: Trends, complications, repeat surgery, and charges. Spine. 2012;37(3):222-30.
  5. Chen F, Dai Z, Kang Y, Lv G, Keller ET, Jiang Y. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion. Osteoporos Int. 2016;27:1469-76.
  6. Ito Z, Imagama S, Kanemura T, Hachiya Y, Miura Y, Kamiya M, et al. Bone union rate with autologous iliac bone versus local bone graft in posterior lumbar interbody fusion (PLIF): A multicenter study. Eur Spine J. 2013;22:1158-63.
  7. An HS, Lynch K, Toth J. Prospective comparison of autograft vs. allograft for adult posterolateral lumbar spine fusion: Differences among freeze-dried, frozen, and mixed grafts. J Spinal Disord. 1995;8:131-5.
  8. Xue Q, Li H, Zou X, Dalstra M, Lind M, Christensen FB, et al. Alendronate treatment improves bone-pedicle screw interface fixation in posterior lateral spine fusion: An experimental study in a porcine model. Int Orthop. 2010;34:447-51.
  9. Nagahama K, Kanayama M, Togawa D, Hashimoto T, Minami A. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial. J Neurosurg Spine. 2011;14:500-7.
  10. Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, García-Hernandez PA, et al. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res. 2008;23:6-16.
  11. Liu WB, Zhao WT, Shen P, Zhang FJ. The effects of bisphosphonates on osteoporotic patients after lumbar fusion: A meta-analysis. Drug Des Devel Ther. 2018;12:2233-40.
  12. Yalçin N, Öztürk A, Ozkan Y, Çelimli N, Ozocak E, Erdoğan A, et al. The effects of zoledronic acid and hyperbaric oxygen on posterior lumbar fusion in a rabbit model. J Bone Joint Surg Br. 2011;93:793-800.
  13. Bransford R, Goergens E, Briody J, Amanat N, Cree A, Little D. Effect of zoledronic acid in an L6-L7 rabbit spine fusion model. Eur Spine J. 2007;16:557-62.
  14. Park YS, Kim HS, Baek SW, Kong DY, Ryu JA. The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. Clin Orthop Surg. 2013;5:292-7. 
  15. Zwolak P, Farei-Campagna J, Jentzsch T, von Rechenberg B, Werner CM. Local effect of zoledronic acid on new bone formation in posterolateral spinal fusion with demineralized bone matrix in a murine model. Arch Orthop Trauma Surg. 2018;138:13-8.
  16. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006;17:897-907.